77703004: Amphotericin B (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antifungal\Amphotericin (substance)\Amphotericin B

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antifungal\Amphotericin (substance)\Amphotericin B

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Lactone (substance)\Macrolide (substance)\Amphotericin (substance)\Amphotericin B

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Amphotericin B	Is a	Amphotericin-containing product	false	Inferred relationship	Some
Amphotericin B	Is a	Amphotericin (substance)	true	Inferred relationship	Some
Amphotericin B	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antifungal	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Accidental amphotericin B poisoning	Causative agent (attribute)	False	Amphotericin B	Inferred relationship	Some
Intentional amphotericin B poisoning	Causative agent (attribute)	False	Amphotericin B	Inferred relationship	Some
intoxication par l'amphotéricine B d'intention indéterminée	Causative agent (attribute)	False	Amphotericin B	Inferred relationship	Some	1
Amphotericin B measurement (procedure)	Has measured component (attribute)	False	Amphotericin B	Inferred relationship	Some
Amphotericin measurement	Has measured component (attribute)	False	Amphotericin B	Inferred relationship	Some
Poisoning by amphotericin B	Causative agent (attribute)	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B measurement (procedure)	Component	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin measurement	Component	False	Amphotericin B	Inferred relationship	Some
Amphotericin b 50mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amphotericin B	Inferred relationship	Some
Amphotericin b 100mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amphotericin B	Inferred relationship	Some
Amphotericin B 30 mg/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amphotericin B	Inferred relationship	Some
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amphotericin B	Inferred relationship	Some
Amphotericin b 50mg powder for infusion solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amphotericin B	Inferred relationship	Some
Amphotericin b 100mg/mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amphotericin B	Inferred relationship	Some
Amphotericin b 5mg/mL infusion solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amphotericin B	Inferred relationship	Some
Amphotericin B liposome (substance)	Is a	False	Amphotericin B	Inferred relationship	Some
Accidental amphotericin B poisoning	Causative agent (attribute)	True	Amphotericin B	Inferred relationship	Some	1
Intentional amphotericin B poisoning	Causative agent (attribute)	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B cholesteryl sulfate complex (substance)	Is a	False	Amphotericin B	Inferred relationship	Some
Amphotericin B lipid complex (substance)	Is a	False	Amphotericin B	Inferred relationship	Some
Intentional amphotericin B overdose	Causative agent (attribute)	True	Amphotericin B	Inferred relationship	Some	1
Accidental amphotericin B overdose	Causative agent (attribute)	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B overdose	Causative agent (attribute)	True	Amphotericin B	Inferred relationship	Some	1
surdose d'amphotéricine B d'intention indéterminée	Causative agent (attribute)	False	Amphotericin B	Inferred relationship	Some	1
Amphotericin b 50mg infusion solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amphotericin B	Inferred relationship	Some
Product containing amphotericin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Product containing amphotericin B in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Product containing amphotericin B in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Amphotericin B	Inferred relationship	Some
Amphotericin B cholesteryl sulfate complex (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	False	Amphotericin B	Inferred relationship	Some
Amphotericin B lipid complex (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	False	Amphotericin B	Inferred relationship	Some
Amphotericin B liposome (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Amphotericin B	Inferred relationship	Some
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Amphotericin B	Inferred relationship	Some	1
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B phospholipid complex (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	False	Amphotericin B	Inferred relationship	Some
Amphotericin B 50 mg powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B 50 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Amphotericin B	Inferred relationship	Some	1
Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Amphotericin B	Inferred relationship	Some	1
Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Amphotericin B	Inferred relationship	Some	1
Product containing amphotericin B in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B-containing product in oromucosal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Product containing only amphotericin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Product containing only amphotericin B in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Product containing only amphotericin B in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Product containing only amphotericin B in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Amphotericin B	Inferred relationship	Some	1
Product containing precisely amphotericin B 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Amphotericin B	Inferred relationship	Some	1
Product containing precisely amphotericin B 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B 30 mg/mL cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Amphotericin B	Inferred relationship	Some	1
Amphotericin B 30 mg/mL cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Amphotericin B	Inferred relationship	Some	1
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Amphotericin B	Inferred relationship	Some	1
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Amphotericin B	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
128963013	Amphotericin B	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
818563012	Amphotericin B (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
56301000195110	amfotericina B	it	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
791411000172114	amphotéricine B	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
71291000195118	Amphotericin B	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module